Compound class:
Synthetic organic
Comment: Abimtrelvir is a newly proposed INN for an antiviral that was revealed in January 2022, in the COVID special section of Proposed List 126. It is therefore assumed to target SARS-CoV-2, and to be a potential drug for the treatment of patients with SARS-CoV-2 infection (COVID-19). Abimtrelvir appears to be from the same chemical series as ensitrelvir.
|
|
No information available. |